Simplifying Global Compliance
FDAnews Drug Daily Bulletin
FDA Reviewer Not Sold on Increased Restrictions for Hydrocodone Combos
Jan. 24, 2013
The FDA appears poised to oppose a Drug Enforcement Administration (DEA) proposal to place increased restrictions on hydrocodone-containing drug combination products. DEA is weighing whether to up-schedule the painkillers from Schedule III to Schedule II, but must first receive an evaluation and recommendation from the FDA.
Drug Industry Daily
Copyright ©2019. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing